Navigation Links
Takeda Responds to Judgment in Diabetes Drug Case
Date:9/3/2014

DEERFIELD, Ill. and OSAKA, Japan, Sept. 3, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that judgment was entered on the jury verdict that was returned on April 7, 2014, in the case of Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al. (U.S. Dist. Ct., W. Dist. of Louisiana, Case No. 12-0064).  The court has yet to rule on Takeda and Eli Lilly & Co.'s post-trial motion for a new trial, or alternatively, a significantly reduced punitive damage award. 

"We respectfully disagree with the judgment and await a ruling on our motion for a new trial, or alternatively, a significantly reduced punitive damage award," said Kenneth D. Greisman, senior vice president and general counsel, Takeda Pharmaceuticals U.S.A., Inc.  "The ruling on that motion is expected in the coming weeks."

Takeda has prevailed in all five ACTOS (pioglitazone HCl) cases tried in state courts thus far. The Allen case is the only case to reach trial in the multidistrict litigation pending in the federal courts.

"Patient safety is a critical priority for Takeda," said Greisman. "We believe we acted responsibly with regard to ACTOS and plan to vigorously defend the company against these lawsuits. We will challenge this verdict through all available legal means, and will appeal the outcome to a higher court."

Indication for ACTOS
ACTOS (pioglitazone) is a prescription medicine used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. ACTOS is not for the treatment of type 1 "juvenile" diabetes or diabetic ketoacidosis (increased ketones in blood or urine).

Importan
'/>"/>

SOURCE Takeda Pharmaceuticals U.S.A., Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
2. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
3. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
4. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
5. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
6. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
7. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
8. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
9. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
10. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
11. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... N.J. and LOS ANGELES ... Diagnostics (NYSE: DGX ), the world,s leading ... it has completed the previously announced acquisition of ... As a result of the transaction, ... extensive range of innovative services and network of ...
(Date:8/4/2015)... , Aug. 4, 2015  Armada Health ... Massachusetts Medical School,s Clinical Pharmacy Services business ... clinical protocols and therapy interventions within the ... Specialty medication therapy management is an ... ensure optimal patient outcomes are achieved through ...
(Date:8/4/2015)... , August 4, 2015 Transparency ... Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and ... a new market report published by Transparency Market Research ... Size, Volume, Share, Growth, Trends and Forecast 2014 - ...
Breaking Medicine Technology:Quest Diagnostics Completes Acquisition of MemorialCare Health System's Laboratory Outreach Service Business in Southern California 2Armada Health Care collaborates with University of Massachusetts Medical School for ArmadaOne Specialty Pharmacy Platform 2Armada Health Care collaborates with University of Massachusetts Medical School for ArmadaOne Specialty Pharmacy Platform 3Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 2Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 3Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 4Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 5
... Inc. (OTC/BB: TBIO) today announced the ... to aid physicians in the diagnosis of mitochondrial disorders. ... identify mutations in more than 400 genes, and represents ... The announcement was made at the 2011 United Mitochondrial ...
... YORK, June 16, 2011 Reportlinker.com announces that ... its catalogue: UK CT Systems ... http://www.reportlinker.com/p0555197/UK-CT-Systems-–-Market-Trend-Till-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging Short Description ... market data on the CT systems in UK. ...
Cached Medicine Technology:Transgenomic, Inc. Launches Best-in-Class Next-Generation Sequencing Test for Nuclear Mitochondrial Disorders at the 2011 United Mitochondrial Disease Foundation Meeting 2Transgenomic, Inc. Launches Best-in-Class Next-Generation Sequencing Test for Nuclear Mitochondrial Disorders at the 2011 United Mitochondrial Disease Foundation Meeting 3Reportlinker Adds UK CT Systems - Market Trend Till 2016 2
(Date:8/4/2015)... (PRWEB) , ... August 05, 2015 , ... The ... Pain and Obesity ”. , As corresponding author Professor Akiko Okifuji says “Both obesity ... often, although it is not to say that one causes the other. Rather, there ...
(Date:8/4/2015)... ... 2015 , ... Exsurco Medical, Inc. is proud ... as an Affiliate Member. Exsurco Medical finds this an exciting opportunity to ... lives by promoting the safety, quality and availability of donated tissue for transplantation, ...
(Date:8/4/2015)... ... 2015 , ... The United Nations Foundation today announced a ... for a select group of U.S.-based journalists during the week of November 9, ... International Conference on Family Planning in Bali. , In close coordination with ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... formula. Healthy Origins® Cognizin® is a trademark for Citicoline, a nutrient that ... a capsule for those applications which have more of a semi-solid composition. ...
(Date:8/4/2015)... ... 2015 , ... Bayco Products, Inc. announces a new industrial-grade LED Dual-LightTM headlamp ... hats that have a flip-up face shield. The sleek contours of the new ... to remove their headlamp when raising or lowering their face shield or visor. The ...
Breaking Medicine News(10 mins):Health News:The Association between Chronic Pain and Obesity published by Dove Medical Press 2Health News:Exsurco Medical Joins AATB as Affiliate Member 2Health News:UN Foundation Announces Press Fellowship to Indonesia with Focus on Women’s Health and Rights 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 3Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 3
... in Wonderland was well advised to stay asleep especially as ... in the tea-time conversation. Dormice in Europe spend about eight ... extended period, with almost all of them surviving the winter. ... Austria, the Czech Republic, England, Germany and Italy. Karin Lebl ...
... close attention to how the United Kingdom carries out plans ... beyond clinical and cost effectiveness, according to researchers at the ... to appear in the April 7 issue of the ... discuss a new, "value-based pricing" policy proposed by the British ...
... -- Having a good laugh on April Fool,s Day or ... benefits your blood vessels, an expert says. "Laughter increases ... stress is especially beneficial for persons who have hypertension [high ... Vascular Surgery news release. April is National Stress Awareness ...
... a unique system to perform in vivo RNAi ... that regulate hepatocyte proliferation during chronic liver damage.1 ... stable knockdown of the candidate gene by different ... mouse hepatocytes and also increase the regenerative capacity ...
... 1 issue of the journal SLEEP demonstrates that an ... sleep disturbances, as well as providing positive, indirect benefits ... that the Internet can give parents widespread access to ... children. Results show that there were significant improvements ...
... Researchers have found that it may not be necessary to ... analyzing non-tumor tissue may be an effective option, according to ... of the American Association for Cancer Research. "A ... detect the presence of tumor," said lead researcher Dan Mercola, ...
Cached Medicine News:Health News:Sleeping through danger: the dormouse approach to survival 2Health News:Placing value, price on new drugs: The challenge facing new UK policy, say Hopkins bioethicists 2Health News:Placing value, price on new drugs: The challenge facing new UK policy, say Hopkins bioethicists 3Health News:Internet program reduces infant and toddler sleep problems, helps moms sleep better too 2Health News:Internet program reduces infant and toddler sleep problems, helps moms sleep better too 3Health News:New tool allows for an alternate method of prostate cancer diagnosis 2
For the quantitative in vitro determination of creatinine in serum, plasma or urine....
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum...
For the quantitative in vitro determination of IgE in Human Serum or Plasma....
Medicine Products: